Abstracts

PULMONARY CMV REACTIVATION FOLLOWING SARS-CoV-2: IMPLICATIONS FOR IMMUNOPATHOLOGY

SARS-CoV-2 infection results in a spectrum of disease severity attributable to the magnitude of the underlying inflammatory response. Aged individuals with co-morbidities are most vulnerable and severely affected, but the mechanisms driving aberrant immune responses fueling SARS-CoV-2 immunopathology in this high-risk population are not fully elucidated. We hypothesized that asymptomatic CMV infection might exacerbate SARS-CoV-2…

IDENTIFICATION OF KEY BIOMARKERS FOR THE PREDICTION OF CRITICAL COVID-19 OUTCOMES

Understanding the role of crucial biomolecules and mechanistic pathways supporting coronavirus disease 2019 (COVID-19) pathophysiology is essential to handle the immune dysregulation and complications driven by uncontrolled severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. Thus, we evaluated the proteomics, metabolomics and lipidomics plasma profile in a well-characterized cohort of COVID-19 patients ranging from asymptomatic…

MACHINE LEARNING ANALYSIS OF DNA METHYLATION IN COVID-19 DISEASE

SARS-CoV-2 infection has resulted in over 219 million confirmed cases of COVID-19 with 4.5 million fatalities, highlighting the importance of elucidating mechanisms of severe disease. Here we utilized machine learning (ML) technologies to identify DNA methylation footprints of COVID-19 disease from publicly available data. Genome-wide DNA methylation of SARS-COV-2 infected and uninfected patients using Illumina…

IMMUNE EXHAUSTION IS ASSOCIATED WITH PERSISTENT SARS-CoV-2 VIREMIA AND SEVERE DISEASE

SARS-CoV-2 viremia is associated with adverse outcomes in COVID-19. The immunologic mediators of this relationship remain under-explored. In this study, we aimed to evaluate the correlation between immune exhaustion markers, SARS-CoV-2 viremia clearance and clinical outcomes. We included 126 participants with confirmed SARS-CoV-2 infection who were hospitalized at an urban hospital in Boston, Massachusetts, during…

CIRCULATING LEVELS OF TYPE I, TYPE II, AND TYPE III INTERFERONS AND COVID-19 SEVERITY

Interferons play a pivotal role as a first line of the innate immune host response to viral infections, including COVID-19. Accumulating data suggests dysregulated interferon (IFN) responses in COVID-19. However, the clinical relevance of circulating levels of interferon to COVID-19 disease severity remains unclear In plasma from individuals with PCR confirmed SARS-CoV-2 infection recruited to…

TGF-?2 IS ASSOCIATED WITH ASYMPTOMATIC/MILD SARS-CoV-2 INFECTION DURING PREGNANCY

COVID-19 has been a devastating disease and a major public health concern mainly to susceptible populations. We accessed two groups of pregnant women at the time of delivery: SARS-CoV2 active infection and convalescents. To investigate the factors contributing to COVID19 severity we have assessed several immunological parameters including cytokines/chemokine levels in the maternal and cord…

ANTI-?4?7 ANTIBODY REDUCES INTESTINAL MYELOID CELL TURNOVER IN SIV-INFECTED MACAQUES

Despite advances in combination antiretroviral therapy (cART), HIV-infected individuals experience gastrointestinal symptoms and gut barrier dysfunction. Previous studies indicate anti-?4?7 integrin monoclonal antibodies (mAbs) reduce gut lymphoid aggregation in the gut and more recently, that they increased time to viral rebound when co-administered with broadly neutralizing Abs in SIV-infected macaques. However, the impact of anti-?4?7…